Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Immunol ; 48(6): 1059-1073, 2018 06.
Article in English | MEDLINE | ID: mdl-29460338

ABSTRACT

Endometriosis affects women of reproductive age via unclear immunological mechanism(s). Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid cells with potent immunosuppressive and angiogenic properties. Here, we found MDSCs significantly increased in the peripheral blood of patients with endometriosis and in the peritoneal cavity of a mouse model of surgically induced endometriosis. Majority of MDSCs were granulocytic, produced ROS, and arginase, and suppressed T-cell proliferation. Depletion of MDSCs by antiGr-1 antibody dramatically suppressed development of endometrial lesions in mice. The chemokines CXCL1, 2, and 5 were expressed at sites of lesion while MDSCs expressed CXCR-2. These CXC-chemokines promoted MDSC migration toward endometriotic implants both in vitro and in vivo. Also, CXCR2-deficient mice show significantly decreased MDSC induction, endometrial lesions, and angiogenesis. Importantly, adoptive transfer of MDSCs into CXCR2-KO mice restored endometriotic growth and angiogenesis. Together, this study demonstrates that MDSCs play a role in the pathogenesis of endometriosis and identifies a novel CXC-chemokine and receptor for the recruitment of MDSCs, thereby providing a potential target for endometriosis treatment.


Subject(s)
Angiogenesis Inducing Agents/immunology , Endometriosis/immunology , Endometrium/immunology , Granulocytes/immunology , Myeloid-Derived Suppressor Cells/immunology , Animals , Arginase/metabolism , Cells, Cultured , Chemokines/metabolism , Cytokines/metabolism , Disease Models, Animal , Endometrium/blood supply , Female , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Reactive Oxygen Species/metabolism , Receptors, Interleukin-8B/genetics , Receptors, Interleukin-8B/metabolism
2.
J Pediatr Surg ; 51(9): 1462-6, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27032613

ABSTRACT

OBJECTIVE: To investigate the risk of gonadal germ cell neoplasms (GCN) in children with 45,X/46,XY gonadal dysgenesis and its relation to the clinical presentations. METHODS: We conducted a retrospective study reviewing the clinical and gonadal features of all consecutive children with 45,X/46,XY gonadal dysgenesis who received gonadal management in a tertiary center from 1985 to 2015. Study subjects were divided into Group I(significant genitalia anomaly), Group II(female phenotype) and Group III(male phenotype). RESULTS: 21 children were studied (Group I=8; Group II=11; Group III=2). All 19 children of Group I and II eventually underwent bilateral gonadectomy. One patient of Group III underwent gonadal biopsy which showed increase in fibrous tissue in the testes without any GCN. 3/8(37.5%) and 6/11(54.5%) of patients in Group I and II respectively had either gonadoblastoma (GB) or carcinoma-in-situ (CIS) or both affecting one or both gonads. Among Group I patients, the 4 dysgenetic testes affected by CIS in 3 patients were intraabdominal (n=1), inguinal (n=1) and scrotal (n=2) in positions. Among Group II patients, 6/20 streak gonads had GB and 2/2 dysgenetic testes had GB or CIS. CONCLUSIONS: 45,X/46,XY children with significant genitalia anomaly or female phenotype are both at high risk of gonadal GCN.


Subject(s)
Carcinoma in Situ/etiology , Gonadal Dysgenesis, 46,XY/complications , Gonadoblastoma/etiology , Ovarian Neoplasms/etiology , Testicular Neoplasms/etiology , Turner Syndrome/complications , Carcinoma in Situ/diagnosis , Carcinoma in Situ/surgery , Child , Child, Preschool , Female , Gonadal Dysgenesis, 46,XY/diagnosis , Gonadal Dysgenesis, 46,XY/surgery , Gonadoblastoma/diagnosis , Gonadoblastoma/surgery , Humans , Infant , Male , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/surgery , Retrospective Studies , Risk Factors , Testicular Neoplasms/diagnosis , Testicular Neoplasms/surgery , Turner Syndrome/diagnosis , Turner Syndrome/surgery
3.
Aust N Z J Obstet Gynaecol ; 53(2): 170-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23488984

ABSTRACT

BACKGROUND: The management of first-trimester miscarriage has been studied extensively in recent years. However, relatively little attention has been focussed on woman's satisfaction and psychological impact from different treatment modalities. AIM: To investigate the clinical and psychological outcomes of surgical, medical and expectant management of first-trimester miscarriage. MATERIALS AND METHODS: A prospective randomised controlled trial of 180 women suffering miscarriage managed by either surgical evacuation, medical evacuation or expectant management was conducted in a university-affiliated, tertiary referral hospital. The complete miscarriage rate, clinical symptomatology, complications, women's satisfaction and the psychological impact were evaluated. RESULTS: Women in surgical evacuation (98.1%) had a significantly higher complete miscarriage rate when compared with medical evacuation (70%) and expectant management (79.3%). Women who had surgical evacuation had significantly shorter duration of vaginal bleeding, but higher rate of infection. Women who had medical evacuation had significantly more gastrointestinal symptoms. Despite differences in efficacy and complication profile, there was no significant difference in satisfaction among groups. There were no significant differences in terms of psychological well-being, depression scores, anxiety level, fatigue symptoms as measured in General Health Questionnaire-12, Beck Depression Inventory, Spielberger's State Anxiety Inventory and fatigue scale at treatment and four weeks after treatment. However, women with active intervention had greater post-traumatic stress symptoms as measured in Chinese version of Impact of Event Scale-Revised at the time of treatment when compared with women in expectant management. CONCLUSION: Without substantial differences in the clinical and psychological impact between different treatment modalities, a more conservative approach with expectant management for miscarriage may be an option for women.


Subject(s)
Abortifacient Agents, Nonsteroidal , Abortion, Spontaneous/psychology , Abortion, Spontaneous/therapy , Dilatation and Curettage , Misoprostol , Watchful Waiting , Abortifacient Agents, Nonsteroidal/adverse effects , Abortion, Incomplete/etiology , Adult , Dilatation and Curettage/adverse effects , Dilatation and Curettage/psychology , Female , Humans , Misoprostol/adverse effects , Patient Satisfaction , Pregnancy , Pregnancy Trimester, First , Stress Disorders, Post-Traumatic/etiology , Surveys and Questionnaires , Uterine Hemorrhage/etiology
4.
Gynecol Obstet Invest ; 73(3): 183-8, 2012.
Article in English | MEDLINE | ID: mdl-22398278

ABSTRACT

AIMS: To assess the prevalence of thrombophilia among Chinese women with venous thromboembolism (VTE) developed during pregnancy. METHODS: Based on information from a tertiary teaching unit, all recorded cases of deep vein thrombosis (DVT) and pulmonary embolism (PE) during pregnancy diagnosed between 1997 and 2005, were assessed for prevalence of thrombophilia. Fifty-five healthy women, who had at least one normal pregnancy but without any previous history of VTE, were recruited as controls. RESULTS: A total of 44 subjects completed thrombophilia screening, of whom 5 (11%) were confirmed to have thrombophilia [protein C (PC) deficiency (2), protein S (PS) deficiency (1), combined PC & PS deficiency (1) and antithrombin III deficiency (1)]. Homozygous 5,10-methylenetetrahydrofolate reductase (C677T) gene mutation was found in 6 (14%) subjects but not in the controls. There was no antiphospholipid syndrome, activated PC resistance, factor V Leiden or prothrombin gene mutations. CONCLUSION: In the Chinese population, PS and PC deficiencies are common thrombophilia for VTE during pregnancy and thrombophilia screening should be recommended in all pregnant women who suffer from VTE.


Subject(s)
Pregnancy Complications, Hematologic , Thrombophilia/epidemiology , Venous Thrombosis/epidemiology , Activated Protein C Resistance/epidemiology , Adult , Antithrombin III Deficiency/epidemiology , Asian People/ethnology , Case-Control Studies , Cohort Studies , DNA Primers/chemistry , Factor V/genetics , Female , Hong Kong/epidemiology , Humans , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Mutation , Pregnancy , Prevalence , Prospective Studies , Protein C Deficiency/epidemiology , Protein S Deficiency/epidemiology , Prothrombin/genetics , Pulmonary Embolism/epidemiology
5.
Int Urogynecol J ; 22(10): 1305-12, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21611791

ABSTRACT

INTRODUCTION AND HYPOTHESIS: The purpose of this study was to investigate the reliability and validity of the Chinese version of Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). METHODS: Women who presented for pelvic floor disorders completed the Chinese version of PFDI and PFIQ, SF-36, a 3-day urinary and fecal diary. POP-Q assessment, urodynamic study, anal manometry, and ultrasound were performed where appropriate. RESULTS: Five hundred and ninety-seven women completed the study. The Cronbach's alpha and test-retest reliability of PFDI and PFIQ was 0.92 and 0.98, and 0.77 and 0.79, respectively. Convergent validity was demonstrated with negative correlation of PFDI and PFIQ with SF-36; positive correlation of staging of prolapse, urinary or fecal incontinent episodes with the respective subscales of PFDI and PFIQ. CONCLUSIONS: The Chinese version of PFDI and PFIQ are reliable and valid condition-specific health-related quality of life questionnaires for women with pelvic floor disorders.


Subject(s)
Language , Pelvic Floor Disorders/physiopathology , Pelvic Floor Disorders/psychology , Quality of Life/psychology , Surveys and Questionnaires , Adult , Aged , Aged, 80 and over , China , Female , Humans , Manometry , Middle Aged , Pelvic Floor Disorders/diagnostic imaging , Reproducibility of Results , Ultrasonography , Urodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...